Andhra Pradesh, India

N V Raghavalu Dusanapudi

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Apicore US LLC. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: N V Raghavalu Dusanapudi. Retrieved from https://idiyas.com/inventor/n-v-raghavalu-dusanapudi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: N V Raghavalu Dusanapudi: Innovator in Pharmaceutical Chemistry

Introduction

N V Raghavalu Dusanapudi is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of complex compounds. His work has implications for the development of important therapeutic agents.

Latest Patents

Dusanapudi holds a patent for "Methods of making carfilzomib and intermediates thereof." This patent discloses racemization-free methods for the synthesis of carfilzomib, a drug used in cancer treatment. The patent also includes novel intermediates and methods of making carfilzomib through fragment condensation. Additionally, it covers the production of amorphous carfilzomib and methods for its synthesis. He has 1 patent to his name.

Career Highlights

Dusanapudi is currently associated with Apicore US LLC, where he continues to advance his research in pharmaceutical innovations. His expertise in synthetic methods has positioned him as a valuable asset in the industry.

Collaborations

Some of his notable coworkers include Ravishanker Kovi and Jayaraman Rao Kannapan. Their collaborative efforts contribute to the innovative environment at Apicore US LLC.

Conclusion

N V Raghavalu Dusanapudi exemplifies the spirit of innovation in pharmaceutical chemistry through his groundbreaking work and patent contributions. His research continues to pave the way for advancements in drug synthesis and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…